Study in "Translational Psychiatry" explores plasma proteins related to the p-factor in young adults, revealing potential biomarkers for overall mental health status and insights into common ...

A recent study from Harvard Medical School asks whether the element lithium might be a key factor in whether someone develops Alzheimer’s disease.

Plasma p-tau217 detected plaques and tangles in cognitively normal and impaired adults. The marker also pegged people with rapid memory decline. Screening with p-tau217 may halve the number of trial ...

That said, traditionally, the gold standard for gauging pathology has been analyzing brain tissue postmortem. To begin the process of validating plasma markers against tissue neuropathology, Gemma ...

The results suggest that plasma PTX3 levels may not only be laboratory values that differentiate NASH from non-NASH, but marker of the severity of hepatic fibrosis in NASH.

New research published in the July issue of the Journal of the American College of Surgeons shows elevated plasma DNA is a reliable marker of recurrent esophageal cancer. The study also suggests ...

Results from the Extension phase showed that neflamapimod continued to slow disease progression and impacted a key plasma marker of neurodegeneration in DLB patients.

Plasma ctDNA response is an early phenomenon, with the majority of change detectable within the first cycle of therapy. These kinetics may offer an opportunity for early insight into treatment effect ...

Plasma PTX3 measurements may be noninvasive and appear to show promise as a means to differentiate NASH from non-NASH patients, and as a clinical marker of the severity of liver fibrosis in NASH ...